The two are hot topics, but how do they combine in the arena of HIV? That's what two lectures at Grand Valley State University's Allendale Campus will explore on April 13. The first lecture is by ...

The conference emphasized advancements in HIV pathogenesis, persistence, and gene therapy, alongside policy and drug use intersections. Lenacapavir was found safe in adolescents, offering new insights ...

《柳叶刀》（The ...

The Boston University Frederick S. Pardee School of Global Studies on 121 Bay State Road. Pardee hosted its Global Health Politics Workshop which featured a lecture on HIV treatment research in Africa ...

Since then, he s shot for numerous publications in African, Spain, and Thailand. Locally, his work has appeared in the Tri-State Defender. He also happens to be HIV positive, and he ll be speaking at ...

Overall, the story of HIV is one of astounding success. But to declare victory, it will be necessary to develop a vaccine. The opening session of the 31st Conference on Retroviruses and Opportunistic ...

ART scale-up to ~80% coverage by 2024 reduced AIDS deaths from ~2 million (2004) to just over 500,000 annually, alongside a 40% decline in incident infections since 2010. Regional divergence is ...

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by ...